ILEP is proud to be a founding member of the Global Partnership for Zero Leprosy – a new partnership designed to align the leprosy community and to accelerate effective collaboration towards the goal of zero leprosy.
Who are the partners?
ILEP was instrumental in establishing the Global Partnership for Zero Leprosy alongside other leading leprosy organizations, including the Novartis Foundation, and the International Association for Integration, Dignity and Economic Advancement (IDEA), with representation from national leprosy programs, scientific organizations and the academic community, and with support from the World Health Organization (WHO).
The secretariat for the Global Partnership is hosted by the Task Force for Global Health who host a number of other NTD networks.
What will the partnership do?
Initially, the Global Partnership for Zero Leprosy will coordinate action in three key areas:
- Accelerating research in new diagnostic and therapeutic tools, interventions, and strategies to interrupt leprosy transmission.
- Working with national leprosy programs to scale up promising innovations.
- Increasing advocacy and fundraising.
ILEP will contribute to all three of these areas and take a lead role in the second group focused on operational excellence within the partnership.
The Global Partnership for Zero Leprosy was publicly launched just before World Leprosy Day in January 2018.
The ILEP secretariat and members have been involved since the Beijing ILC meeting in September 2016 in shaping the partnership, and will continue to do so with ILEP CEO Tanya Wood, with support by Jan van Berkel on the leadership team.
Leprosy stakeholder survey, conducted March – June 2017 http://ilepfederation.org/news-item/survey-reveals-enthusiasm-for-proposed-global-partnership-for-zero-leprosy-transmission/
Leadership team meeting notes – to be added
ILEP members are contributing financially to the global partnership in this first year, 2018. This includes funding a new position of Operational Excellence coordinator for Working Group 2.
Funding is also being provided by the Novartis Foundation. It is anticipated that the Global Partnership for Zero Leprosy secretariat, hosted by The Task Force for Global Health, will attract more funding for its operations in future years.
For more information, visit www.zeroleprosy.org.